Answer
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead is indicated from age 2 years and body weight 14 kg for HIV-1 infection without known resistance-associated mutations to integrase inhibitors, emtricitabine or tenofovir.
Sources for this answer
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead 150mg/150mg/200mg/10mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 37Document updated
Sources checked